Glen D. Morgan, PhD; Victor G. Villagra, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: The nicotine transdermal patch, the newest pharmacologic adjunct for smoking cessation, has recently been introduced in the United States. Two recent reviews of this product concluded that it is effective (1, 2). The reviewers raised concerns about its long-term effectiveness and the generalizability of results (1), and they pointed out the importance of concomitant behavioral modification (2). Based on our experience with nicotine gum, we would add an additional concern: its potential for misuse.
The results of early nicotine gum trials raised unrealistic expectations (3, 4). Nicotine replacement was often overprescribed or used without behavioral modification. Disappointing
Morgan GD, Villagra VG. The Nicotine Transdermal Patch: A Cautionary Note. Ann Intern Med. ;116:424. doi: 10.7326/0003-4819-116-5-424_1
Download citation file:
Published: Ann Intern Med. 1992;116(5):424.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use